N-[(1R,2S,5S)-6-BENZYL-8-METHYL-6,8-DIAZABICYCLO-[3.2.2]-NONAN-2-YL]-2-(3,4-DICHLOROPHENYL)-ACETAMIDE
Compound with spectra: 1 NMR
![N-[(1R,2S,5S)-6-BENZYL-8-METHYL-6,8-DIAZABICYCLO-[3.2.2]-NONAN-2-YL]-2-(3,4-DICHLOROPHENYL)-ACETAMIDE](/api/compound/46fKMMtUQaW.png?ph=true&h=300&w=458 "N-[(1R,2S,5S)-6-BENZYL-8-METHYL-6,8-DIAZABICYCLO-[3.2.2]-NONAN-2-YL]-2-(3,4-DICHLOROPHENYL)-ACETAMIDE")
| SpectraBase Compound ID | 46fKMMtUQaW |
|---|---|
| InChI | InChI=1S/C23H27Cl2N3O/c1-27-14-18-8-10-21(22(27)15-28(18)13-16-5-3-2-4-6-16)26-23(29)12-17-7-9-19(24)20(25)11-17/h2-7,9,11,18,21-22H,8,10,12-15H2,1H3,(H,26,29)/t18-,21-,22+/m0/s1 |
| InChIKey | NRAWANUJKHXLRC-YUXAGFNASA-N |
| Mol Weight | 432.4 g/mol |
| Molecular Formula | C23H27Cl2N3O |
| Exact Mass | 431.153118 g/mol |
| Enantiomer InChIKey | NRAWANUJKHXLRC-QIJUGHKUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(+)-4-{[(1R,4R,5S)-8-Allyl-4-benzyloxy-6,8-diazabicyclo[3.2.2]non-6-yl]methyl}-N,N-diethylbenzamide
(-)-(1R,2S,5S)-6-Allyl-8-(4-methoxybenzyl)-2-phenoxy-6,8-diazabicyclo[3.2.2]nonane
(+)-(1R,2R,5S)-6-Allyl-8-(4-methoxybenzyl)-2-phenoxy-6,8-diazabicyclo[3.2.2]nonane
(-)-(1R,2S,5S)-6-Allyl-2-benzyloxy-8-(4-methoxybenzyl)-6,8-diazabicyclo[3.2.2]nonane
2-[4-BENZYL-(2S)-[(1S)-[(TERT.-BUTOXYCARBONYL)-AMINO]-2-PHENYLETHYL]-5-OXO-PIPERAZIN-1-YL]-ACETIC-ACID
(+)-2-(3,4-DICHLOROPHENYL)-1-[(R)-4-PHENYL-2-[(S)-1-(PYRROLIDIN-1-YL)-ETHYL]-PIPERAZIN-1-YL]-ETHAN-1-ONE;MAJOR-ROTAMER
1-[(4ARS,5RS,8ASR)-1-BENZOYL-DECAHYDRO-QUINOXALIN-5-YL]-PYRROLIDIN-2-ONE
1-[(4ARS,5SR,8ASR)-1-BENZOYL-DECAHYDRO-QUINOXALIN-5-YL]-PYRROLIDIN-2-ONE
(+)-METHYL-(R)-4-[2-(3,4-DICHLOROPHENYL)-ACETYL]-3-[(S)-1-(PYRROLIDIN-1-YL)-ETHYL]-PIPERAZINE-1-CARBOXYLATE;MAJOR-ROTAMER
| Title | Journal or Book | Year |
|---|---|---|
| Conformationally constrained ethylenediamines: synthesis and receptor binding of 6,8-Diazabicyclo[3.2.2]nonanes | Bioorganic & Medicinal Chemistry | 2002 |